Beauty Health Co
NASDAQ:SKIN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Beauty Health Co
NASDAQ:SKIN
|
US |
|
HSBC Holdings PLC
LSE:HSBA
|
UK |
|
Heineken NV
AEX:HEIA
|
NL |
|
B
|
Bandai Namco Holdings Inc
F:N9B
|
JP |
|
A
|
Analog Devices Inc
XBER:ANL
|
US |
|
Yara International ASA
OSE:YAR
|
NO |
|
A
|
Allstate Corp
XMUN:ALS
|
US |
|
D
|
Dollar Tree Inc
SWB:DT3
|
US |
|
Antofagasta PLC
LSE:ANTO
|
UK |
|
M
|
Mitsui & Co Ltd
XMUN:MTS1
|
JP |
|
A
|
Amgen Inc
XMUN:AMG
|
US |
|
C
|
Compagnie Generale des Etablissements Michelin SCA
F:MCH
|
FR |
|
Christian Dior SE
PAR:CDI
|
FR |
|
H World Group Ltd
OTC:HWLDF
|
CN |
|
S
|
Schneider Electric SE
XHAM:SND
|
FR |
|
DT Midstream Inc
NYSE:DTM
|
US |
|
A
|
Apple Inc
XBER:APC
|
US |
Wall St Price Targets
SKIN Price Targets Summary
Beauty Health Co
According to Wall Street analysts, the average 1-year price target for SKIN is 1.3685 USD with a low forecast of 1.01 USD and a high forecast of 2.1 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SKIN's stock price target?
Price Target
1.3685
USD
According to Wall Street analysts, the average 1-year price target for SKIN is 1.3685 USD with a low forecast of 1.01 USD and a high forecast of 2.1 USD.
What is the Revenue forecast for Beauty Health Co?
Projected CAGR
2%
Over the last 5 years, the compound annual growth rate for Revenue has been 20%. The projected CAGR for the next 3 years is 2%.
What is the Gross Profit forecast for Beauty Health Co?
Projected CAGR
0%
Over the last 5 years, the compound annual growth rate for Gross Profit has been 25%. The projected CAGR for the next 3 years is 0%.
